Taxes
Tax Central: Your essential source for the latest in tax laws, filing tips, and deductions. Ideal for navigating complex tax requirements with ease.
US 100% Tariff on Branded Drugs: Implications and Carve-Outs
Starting October 1, 2025, the U.S. will levy a 100% tariff on imported branded/patented drugs, with an exemption for firms actively building U.S. plants. Generics appear excluded for now, but…
Funding EB-5 from India under RBI LRS: pooling, gifts, and steps
Families use RBI’s LRS (USD 250,000 per year) plus co-ownership, cross-year timing, or gifts to assemble EB-5 capital.…
US Pushes Market Reforms on India and Brazil Amid Tariff Pressure
The U.S. imposed heavy 2025 tariffs—50% on many Indian and Brazilian exports—and tightened de minimis rules to pressure…
India-U.S. Talks Face Section 232 Tariffs, Casting Doubt on a Deal
The U.S. widened Section 232 probes into key sectors, including a planned 100% pharma tariff from October 2025,…
Finance Ministry: H-1B Fee Shock Real, Yet Manageable for India
India says the U.S. one-time USD 100,000 H-1B fee risks IT export earnings and jobs but can be…
Why Make America Great Again Persists Despite U.S. Global Lead
The White House plan imposes a 10% baseline tariff, higher targeted duties including 100% on some Indian drugs,…
H-1B Fee Hike Spurs Remote Overseas Hiring by U.S. Firms
Effective September 21, 2025, a $100,000 surcharge applies to new H-1B petitions, with no payment process yet available.…
India Could Benefit as U.S. H-1B Fee Pushes Talent Home
The U.S. will impose a $100,000 one-time fee on new H-1B petitions filed after September 21, 2025, exempting…
How International Students Subsidize U.S. Education—and the H-1B Crackdown
A proposed $100,000 one-time fee on new H-1B petitions could deter international students, cut university revenues (potentially $3…
Accenture H-1B Fee Seen as Non-Issue, Yet Data Signals Ripple Effects
Julie Sweet called the $100,000 one-time H-1B fee a “non-issue,” yet Accenture filed 1,568 H-1B petitions in H1…